
Exsure is building exosome infrastructure for precision therapeutics. We are developing next-generation drug delivery platforms designed to target cancer stem cells — the root drivers of tumor relapse and resistance. By combining exosome engineering with targeted delivery, our approach aims to improve therapeutic precision while reducing systemic toxicity. Our work focuses on enabling a new paradigm in oncology: treating not just tumors, but the underlying biology that causes recurrence. In parallel, we are building foundational infrastructure for the exosome ecosystem, including: •…
Annual Revenue$1M to $5M
Estimated OwnershipPrivateBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Matching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.